Fukiic acid



Compound IDCDAMM01496
Common nameFukiic acid
IUPAC name2-[(3,4-dihydroxyphenyl)methyl]-2,3-dihydroxybutanedioic acid
Molecular formulaC11H12O8

Experimental data

Retention time11.42
Adduct[M+H]+
Actual mz273.061
Theoretical mz273.06
Error3.38
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.2917

Identifiers and class information

Inchi keyPHFSBARLASYIFM-LDYMZIIASA-N
SmilesO=C(O)C(O)C(O)(C(=O)O)CC1=CC=C(O)C(O)=C1
SuperclassPhenylpropanoids and polyketides
ClassPhenylpropanoic acids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)9
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)272.211
Computed dipole moment(dipole)1.137
Total solvent accessible surface area (SASA)456.546
Hydrophobic component of SASA (FOSA)41.475
Hydrophilic component of SASA (FISA)317.335
Pie component of the SASA (PISA)97.736
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)780.458
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)5.95
Free energy of solvation of dipole (dip^2/V)0.0016566
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0260653
Globularity descriptor (glob)0.89794
Predicted polarizability in cubic angstroms (QPpolrz)20.234
Predicted hexadecane/gas partition coefficient (QPlogPC16)9.446
Predicted octanol/gas partition coefficient (QPlogPoct)15.973
Predicted water/gas partition coefficient (QPlogPw)13.375
Predicted octanol/water partition coefficient (QPlogPo/w)0.395
Predicted aqueous solubility (QPlogS)-1.287
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.702
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-0.035
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.622
Predicted brain/blood partition coefficient (QPlogBB)-2.603
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.274
Predicted skin permeability, log Kp (QPlogKp)-6.16
PM3 calculated ionization potential (IP(ev))8.95
PM3 calculated electron affinity (EA(eV))0.021
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-1.021
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)12.611
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)173.3
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P06241FYNTyrosine-protein kinase FYNT17980SEA
P02766TTRTransthyretinT86462SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P08908HTR1ASerotonin 1a (5-HT1a) receptorT78709SwissTargetPrediction
Q6B0I6KDM4DLysine-specific demethylase 4DT17036SEA
Q96IY4CPB2Carboxypeptidase B2 isoform AT98022SwissTargetPrediction
P07101THTyrosine 3-hydroxylaseT62390SEA
P11511CYP19A1Cytochrome P450 19A1T13260SwissTargetPrediction
Q01650SLC7A5L-type amino acid transporter 1 (by homology)T48330SEA
P16050ALOX15Arachidonate 15-lipoxygenaseT16042SEA
Q02750MAP2K1Dual specificity mitogen-activated protein kinase kinase 1T99057SwissTargetPrediction
P15085CPA1Carboxypeptidase A1T33966SwissTargetPrediction
Q86YT5SLC13A5Solute carrier family 13 member 5T81547SwissTargetPrediction and SEA
P17936IGFBP3Insulin-like growth factor binding protein 3T33455SEA
P53396ACLYATP-citrate synthaseT52189SEA
P24593IGFBP5Insulin-like growth factor binding protein 5T17008SEA
P09172DBHDopamine beta hydroxylaseT74937SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T17980DI0286Myeloproliferative neoplasm[ICD-11: 2A20]P06241FYN
T86462DI0026Amyloidosis[ICD-11: 5D00]P02766TTR
T78709DI0033Anxiety disorder[ICD-11: 6B00-6B0Z]P08908HTR1A
T78709DI0117Depression[ICD-11: 6A70-6A7Z]P08908HTR1A
T78709DI0190Hypertension[ICD-11: BA00-BA04]P08908HTR1A
T78709DI0264Migraine[ICD-11: 8A80]P08908HTR1A
T78709DI0270Mood disorder[ICD-11: 6A60-6E23]P08908HTR1A
T98022DI0073Cerebral ischaemia[ICD-11: 8B1Z]Q96IY4CPB2
T98022DI0074Cerebral ischaemic stroke[ICD-11: 8B11]Q96IY4CPB2
T98022DI0405Thrombosis[ICD-11: DB61-GB90]Q96IY4CPB2
T62390DI0019Adrenomedullary hyperfunction[ICD-11: 5A75]P07101TH
T62390DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P07101TH
T13260DI0062Breast cancer[ICD-11: 2C60-2C6Y]P11511CYP19A1
T13260DI0108Cushing syndrome[ICD-11: 5A70]P11511CYP19A1
T99057DI0262Metastatic tumour[ICD-11: 2D50-2E2Z]Q02750MAP2K1
T99057DI0336Phakomatoses/hamartoneoplastic syndrome[ICD-11: LD2D]Q02750MAP2K1
T33455DI0115Dementia[ICD-11: 6D80-6D8Z]P17936IGFBP3
T52189DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P53396ACLY
T74937DI0175Heart failure[ICD-11: BD10-BD1Z]P09172DBH
T74937DI0341Post-traumatic stress disorder[ICD-11: 6B40]P09172DBH

Copyright © 2025